We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Researchers did not find evidence that treatment gains ...

SEATTLE--(BUSINESS WIRE)--Kubota Vision Inc. (“Kubota Vision” or the “Company”), a clinical-stage specialty ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd ...

Myopia, more commonly known as nearsightedness, is a condition due to the physical length of the eye being relatively too long for its refractive components. Despite its strong family trait, juvenile ...

Research, optical interventions, and education initiatives reflect company’s myopia control & management leadership “No one is doing more than CooperVision to advance the science and practice of ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Repeated ...

Essilorluxottica is currently conducting a clinical study titled A Monocentre, Randomized, Contralateral Trial to Study the Effect of Temporal Changes in Ocular Biometry of Two Myopia Control Lenses.

Please provide your email address to receive an email when new articles are posted on . Experts advise not waiting until children progress to start myopia control. Options include atropine, ...

Chicago, Dec. 05, 2025 (GLOBE NEWSWIRE) -- The Taiwan myopia control lenses market was valued at US$ 49.30 million in 2024 and is projected to reach US$ 140.60 million by 2033, growing at a CAGR of 12 ...

The World Health Organization warns that by 2030, 40% of the world's population will be nearsighted. In the U.S. alone, myopia rates have soared over the past 50 years, from 25% in 1971 to nearly 42% ...